Tissue | Expression Dynamics | Abbreviation |
Colorectum (GSE201348) | | FAP: Familial adenomatous polyposis |
CRC: Colorectal cancer |
Colorectum (HTA11) | | AD: Adenomas |
SER: Sessile serrated lesions |
MSI-H: Microsatellite-high colorectal cancer |
MSS: Microsatellite stable colorectal cancer |
Esophagus | | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
Liver | | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Prostate | | BPH: Benign Prostatic Hyperplasia |
Thyroid | | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0051052 | Colorectum | AD | regulation of DNA metabolic process | 116/3918 | 359/18723 | 2.47e-07 | 1.00e-05 | 116 |
GO:00510521 | Colorectum | SER | regulation of DNA metabolic process | 83/2897 | 359/18723 | 8.03e-05 | 1.77e-03 | 83 |
GO:00510522 | Colorectum | MSS | regulation of DNA metabolic process | 108/3467 | 359/18723 | 5.86e-08 | 3.10e-06 | 108 |
GO:00510524 | Colorectum | FAP | regulation of DNA metabolic process | 84/2622 | 359/18723 | 9.80e-07 | 4.38e-05 | 84 |
GO:00510525 | Colorectum | CRC | regulation of DNA metabolic process | 70/2078 | 359/18723 | 1.75e-06 | 8.92e-05 | 70 |
GO:005105215 | Esophagus | ESCC | regulation of DNA metabolic process | 232/8552 | 359/18723 | 2.40e-13 | 1.13e-11 | 232 |
GO:0051053 | Liver | NAFLD | negative regulation of DNA metabolic process | 26/1882 | 125/18723 | 2.52e-04 | 4.12e-03 | 26 |
GO:00510526 | Liver | NAFLD | regulation of DNA metabolic process | 56/1882 | 359/18723 | 5.95e-04 | 7.92e-03 | 56 |
GO:005105211 | Liver | Cirrhotic | regulation of DNA metabolic process | 114/4634 | 359/18723 | 1.48e-03 | 9.85e-03 | 114 |
GO:005105221 | Liver | HCC | regulation of DNA metabolic process | 198/7958 | 359/18723 | 7.62e-07 | 1.17e-05 | 198 |
GO:00510529 | Prostate | BPH | regulation of DNA metabolic process | 89/3107 | 359/18723 | 4.07e-05 | 4.36e-04 | 89 |
GO:005105212 | Prostate | Tumor | regulation of DNA metabolic process | 88/3246 | 359/18723 | 3.23e-04 | 2.59e-03 | 88 |
GO:005105218 | Thyroid | PTC | regulation of DNA metabolic process | 171/5968 | 359/18723 | 2.52e-10 | 8.33e-09 | 171 |
GO:00510532 | Thyroid | PTC | negative regulation of DNA metabolic process | 53/5968 | 125/18723 | 8.39e-03 | 3.53e-02 | 53 |
GO:005105219 | Thyroid | ATC | regulation of DNA metabolic process | 183/6293 | 359/18723 | 5.97e-12 | 2.30e-10 | 183 |
GO:00510531 | Thyroid | ATC | negative regulation of DNA metabolic process | 57/6293 | 125/18723 | 3.47e-03 | 1.55e-02 | 57 |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
ZNF91 | MLUM | Breast | IDC | N4BP2L2,XIST,SSFA2, etc. | 5.44e-01 | |
ZNF91 | CD8TCM | Cervix | N_HPV | ZNF708,ATM,MTHFR, etc. | 1.10e-01 | |
ZNF91 | M1MAC | Lung | ADJ | AC244131.2,SCGB3A2,SLC12A2, etc. | 1.24e-04 | |
ZNF91 | TFH | Lung | ADJ | AC244131.2,SCGB3A2,SLC12A2, etc. | 1.37e-05 | |
ZNF91 | NEUT | Lung | ADJ | AC244131.2,SCGB3A2,SLC12A2, etc. | 2.62e-03 | |
ZNF91 | MALTB | Lung | ADJ | AC244131.2,SCGB3A2,SLC12A2, etc. | 1.75e-04 | |
ZNF91 | BMEM | Lung | ADJ | AC244131.2,SCGB3A2,SLC12A2, etc. | 8.21e-06 | |
ZNF91 | GC | Lung | ADJ | AC244131.2,SCGB3A2,SLC12A2, etc. | 2.37e-04 | |
ZNF91 | MDSC | Lung | ADJ | AC244131.2,SCGB3A2,SLC12A2, etc. | 0.00e+00 | |
ZNF91 | CD4TN | Oral cavity | EOLP | CD200R1,JHY,PAXIP1-AS2, etc. | 1.44e-01 | |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZNF91 | SNV | Missense_Mutation | novel | c.3011G>A | p.Ser1004Asn | p.S1004N | Q05481 | protein_coding | tolerated(0.64) | benign(0.053) | TCGA-AJ-A3NH-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | CR |
ZNF91 | SNV | Missense_Mutation | rs747255942 | c.2705G>T | p.Arg902Ile | p.R902I | Q05481 | protein_coding | tolerated(0.13) | benign(0.203) | TCGA-AP-A056-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF91 | SNV | Missense_Mutation | | c.2285G>T | p.Arg762Ile | p.R762I | Q05481 | protein_coding | tolerated(0.16) | benign(0.012) | TCGA-AP-A056-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF91 | SNV | Missense_Mutation | rs766711821 | c.1166G>A | p.Arg389Gln | p.R389Q | Q05481 | protein_coding | tolerated(0.94) | benign(0.015) | TCGA-AP-A056-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF91 | SNV | Missense_Mutation | | c.953G>A | p.Gly318Glu | p.G318E | Q05481 | protein_coding | deleterious(0.04) | benign(0.28) | TCGA-AP-A056-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF91 | SNV | Missense_Mutation | rs202143348 | c.997C>T | p.Arg333Cys | p.R333C | Q05481 | protein_coding | tolerated(0.21) | benign(0.006) | TCGA-AP-A05N-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF91 | SNV | Missense_Mutation | | c.781N>A | p.Ala261Thr | p.A261T | Q05481 | protein_coding | tolerated(1) | benign(0.007) | TCGA-AP-A0LG-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF91 | SNV | Missense_Mutation | | c.2285G>A | p.Arg762Lys | p.R762K | Q05481 | protein_coding | tolerated(0.34) | benign(0.049) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
ZNF91 | SNV | Missense_Mutation | novel | c.373G>T | p.Gly125Cys | p.G125C | Q05481 | protein_coding | tolerated(0.1) | benign(0.052) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
ZNF91 | SNV | Missense_Mutation | novel | c.535N>C | p.Lys179Gln | p.K179Q | Q05481 | protein_coding | tolerated(0.07) | benign(0) | TCGA-AP-A1E0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | SD |